Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Ophthalmic Epidemiology|July 16, 2005
Cost-effectiveness of trachoma control in seven world regionsRob M P M Baltussen, Mariame Sylla, Kevin D Frick, et al.International Journal of Technology Assessment in Health Care|May 4, 2002
Uncertainty in cost-effectiveness analysis. Probabilistic uncertainty analysis and stochastic league tablesRob M P M Baltussen, Raymond C W Hutubessy, David B Evans, et al.BMJ Global Health|May 28, 2026
Weak economic evidence for WHO's essential cancer medicines for AfricaAron E van der Steege, James Humuza, Cyprien Shyirambere, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 12, 2006
A dollar is a dollar is a dollar--or is it?Werner B F Brouwer, N Job A van Exel, Rob M P M Baltussen, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|April 14, 2010
Incorporating equity-efficiency interactions in cost-effectiveness analysis-three approaches applied to breast cancer controlStefan A Baeten, Rob M P M Baltussen, Carin A Uyl-de Groot, et al.Nederlands Tijdschrift Voor Geneeskunde|July 17, 2025
[When is a medicine too expensive? Citizen consultation on the societal acceptability of expensive medicines]Rob M P M Baltussen, Leon A Bijlmakers, Maarten P M Jansen, et al.Ophthalmic Epidemiology|November 13, 2007
An eye for inequality: how trachoma relates to poverty in Tanzania and VietnamEvertjan Jansen, Rob M P M Baltussen, Eddy van Doorslaer, et al.BMJ Global Health|June 26, 2026
From implicit to explicit: an evidence-informed deliberative process for health benefits package revision using the WHO UHC Compendium in KyrgyzstanGavin Surgey, Gerard Joseph Abou Jaoude, Baktygul Isaeva, et al.Plos Medicine|February 22, 2017
Evidence for scaling up HIV treatment in sub-Saharan Africa: A call for incorporating health system constraintsEvelinn Mikkelsen, Jan A C Hontelez, Maarten P M Jansen, et al.Pageof 1